Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;3(5):547-551.
doi: 10.1038/s43018-022-00363-4. Epub 2022 Apr 4.

Outcomes of COVID-19 and risk factors in patients with cancer

Manju Sengar #  1 , Girish Chinnaswamy #  1 , Priya Ranganathan  1 , Apurva Ashok  1 , Shilpushp Bhosale  1 , Sanjay Biswas  1 , Pankaj Chaturvedi  1 , Chetan Dhamne  1 , Jigeeshu Divatia  1 , Karishma D'Sa  1 , Hasmukh Jain  1 , Sarbani Laskar  1 , Nirmalya Roy Moulik  1 , Naveen Mummudi  1 , Sindhu Nair  1 , Lingaraj Nayak  1 , Prakash Nayak  1 , Shraddha Patkar  1 , Preeti Pawaskar  1 , Anant Ramaswamy  1 , Omshree Shetty  1 , Arjun Singh  1 , Epari Sridhar  1 , Jayashree Thorat  1 , Rajendra Badwe  1 , C S Pramesh  2 ; TMH COVID-19 action group
Collaborators, Affiliations

Outcomes of COVID-19 and risk factors in patients with cancer

Manju Sengar et al. Nat Cancer. 2022 May.

Abstract

Patients with cancer are at higher risk for adverse coronavirus disease 2019 (COVID-19) outcomes. Here, we studied 1,253 patients with cancer, who were diagnosed with severe acute respiratory syndrome coronavirus 2 at a tertiary referral cancer center in India. Most patients had mild disease; in our settings, recent cancer therapies did not impact COVID-19 outcomes. Advancing age, smoking history, concurrent comorbidities and palliative intent of treatment were independently associated with severe COVID-19 or death. Thus, our study provides useful insights into cancer management during the COVID-19 pandemic.

PubMed Disclaimer

References

    1. Booth, A. et al. Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis. PLoS ONE 16, e0247461 (2021). - DOI
    1. Flook, M. et al. Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality. BMC Infect. Dis. 21, 342 (2021). - DOI
    1. Venkatesulu, B. P. et al. A systematic review and meta-analysis of cancer patients affected by a novel coronavirus. JNCI Cancer Spectr. 5, pkaa102 (2021). - DOI
    1. Robilotti, E. V. et al. Determinants of COVID-19 disease severity in patients with cancer. Nat. Med. 26, 1218–1223 (2020). - DOI
    1. Kuderer, N. M. et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395, 1907–1918 (2020). - DOI

LinkOut - more resources